Results 141 to 150 of about 30,542 (196)

GOTO Transient Discovery Report for 2024-08-23 #2024-3052

Kotak Rubina, Killestein Thomas
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Texto para Discussão 3052

Registros administrativos são essenciais para a elaboração de estatísticas oficiais e orientação das políticas públicas. Este artigo investiga a exatidão da variável de “grau de instrução/escolaridade” nos registros de vínculos de emprego de doutores, na Relação Anual de Informações Sociais (Rais), referentes ao período de 2013 e 2021, considerando-se ...
Daniel Gama e Colombo, Priscila Koeller
openaire   +2 more sources

Abstract 3052: Targeting AXL in PIK3R2-amplified ovarian cancer

Cancer Research, 2020
Abstract The p85 regulatory subunit and its associated p110 catalytic subunit are components of the class IA PI3K that mediates the downstream signal of receptor tyrosine kinases. PIK3R2 (encoding p85β, one of the p85 isoforms) is commonly amplified in ovarian cancer patients.
Ling Rao, Victor C. Mak, Yuan Zhou, Dong Zhang, Xinran Li, Yiling Lu, Gordon B. Mills, Lydia W. Cheung   +7 more
openaire   +2 more sources

Initial efficacy and safety results from ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC).

Journal of Clinical Oncology, 2023
5515 Background: LGSOC is a RAS/MAPK pathway driven cancer that constitutes ≤10% of ovarian cancer. There are no FDA approved treatments specifically for LGSOC. Avutometinib is a novel small molecule RAF/MEK clamp.
Susana Banerjee, K. Ring, E. Van Nieuwenhuysen, M. Fabbro, C. Aghajanian, A. Oaknin, N. Colombo, A. Santin, A. Clamp, K. Moore, P. Rose, D. O’Malley, H. Chon, E. Salinas, E. Prendergast, S. Lustgarten, M. Rodrigues, C. Gennigens, B. Monk, R. Grisham   +19 more
semanticscholar   +1 more source

3052 – EXTENSIVE ANALYSIS OF HEMATOPOIETIC STEM CELLS AFTER SINGLE-CELL TRANSPLANTATION

Experimental Hematology, 2023
Fang Dong, Sen Zhang, Caiying Zhu, Zining Yang, Lisha Wang, Nini Wang, Xiaofang Wang, Yao Ma, Jinhong Wang, Hui Cheng, Sha Hao, Ping Zhu, Berthold Gottgens, Hideo Ema, Tao Cheng   +14 more
openaire   +2 more sources

28. HS 3052

Aramaic Incantation Bowls in Museum Collections, 2019
James Nathan Ford, Matthew Morgenstern
openaire   +2 more sources

Abstract 3052: Patient- and clinician-reported outcomes of radiotherapy-related acute skin toxicities in a tri-racial/ethnic breast cancer population

Cancer Research, 2023
Background: Adjuvant radiotherapy (RT) following surgery significantly improves breast cancer survival. However, some patients, particularly minorities, develop acute skin toxicities that negatively impact their quality of life (QOL). The traditionally
L. G. Acosta, C. Takita, Isilinha M. Reis, J. Wright, Weicheng Zhao, Jennifer J. Hu   +5 more
semanticscholar   +1 more source

Treaty Series 3052

United Nations Treaty Series
openaire   +2 more sources

ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of VS-6766 (RAF/MEK clamp) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC).

Journal of Clinical Oncology, 2022
TPS5615 Background: Low-grade serous ovarian cancer (LGSOC) constitutes up to 10% of all ovarian cancer and has clinical and molecular characteristics distinct from high-grade serous ovarian cancer.
Susana Banerjee, B. Monk, E. Van Nieuwenhuysen, K. Moore, A. Oaknin, M. Fabbro, N. Colombo, D. O’Malley, R. Coleman, A. Oza, J. Pachter, Gloria Patrick, L. Denis, Lorna Leonard, R. Grisham   +14 more
semanticscholar   +1 more source